Douglas Y Mah1, Henry Cheng2, Mark E Alexander2, Lynn Sleeper2, Jane W Newburger2, Pedro J Del Nido3, Ravi R Thiagarajan2, Satish K Rajagopal2. 1. Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, Mass. Electronic address: douglas.mah@cardio.chboston.org. 2. Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, Mass. 3. Department of Cardiovascular Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Mass.
Abstract
OBJECTIVES: Publicly available data from the Pediatric Heart Network's Single Ventricle Reconstruction Trial was analyzed to determine the prevalence, timing, risk factors for, and impact of second- and third-degree heart block (HB) on outcomes in patients who underwent stage 1 palliation (S1P) for hypoplastic left heart syndrome (HLHS). METHODS: The presence and date of onset of post-S1P HB occurring within the first year of life, potential risk factors for HB, and factors known to predict poor outcomes after S1P were extracted. Multivariable logistic and Cox regression analyses were performed to identify risk factors for HB and to determine the effect of HB on 3-year transplantation-free survival. RESULTS: Among the 549 patients in the cohort, 33 (6%) developed HB after S1P. The median interval between S1P and HB was 8 days (interquartile range, 0-133 days). Regression analysis showed that tricuspid valve repair during S1P and obstruction of pulmonary venous drainage requiring pre-S1P intervention were independently associated with HB (adjusted odds ratio [aOR], 11.6, 95% confidence interval [CI] 3.3-40; P < .001 and aOR, 5.1; 95% CI, 1.3-20.6; P = .02, respectively). Transplantation-free survival at 3 years was lower for those with HB (39% vs 65%; P = .004). HB remained associated with transplantation-free survival after controlling for known risk factors (adjusted hazard ratio, 3.1; 95% CI, 1.9-5.0; P < .001). Nine children (27%) had a pacemaker implanted, and 7 of these children (78%) died or underwent heart transplantation. CONCLUSIONS: HB after S1P is rare but heralds a poor outcome. Careful monitoring of these patients is recommended given their significantly increased risks of death and heart transplantation.
RCT Entities:
OBJECTIVES: Publicly available data from the Pediatric Heart Network's Single Ventricle Reconstruction Trial was analyzed to determine the prevalence, timing, risk factors for, and impact of second- and third-degree heart block (HB) on outcomes in patients who underwent stage 1 palliation (S1P) for hypoplastic left heart syndrome (HLHS). METHODS: The presence and date of onset of post-S1P HB occurring within the first year of life, potential risk factors for HB, and factors known to predict poor outcomes after S1P were extracted. Multivariable logistic and Cox regression analyses were performed to identify risk factors for HB and to determine the effect of HB on 3-year transplantation-free survival. RESULTS: Among the 549 patients in the cohort, 33 (6%) developed HB after S1P. The median interval between S1P and HB was 8 days (interquartile range, 0-133 days). Regression analysis showed that tricuspid valve repair during S1P and obstruction of pulmonary venous drainage requiring pre-S1P intervention were independently associated with HB (adjusted odds ratio [aOR], 11.6, 95% confidence interval [CI] 3.3-40; P < .001 and aOR, 5.1; 95% CI, 1.3-20.6; P = .02, respectively). Transplantation-free survival at 3 years was lower for those with HB (39% vs 65%; P = .004). HB remained associated with transplantation-free survival after controlling for known risk factors (adjusted hazard ratio, 3.1; 95% CI, 1.9-5.0; P < .001). Nine children (27%) had a pacemaker implanted, and 7 of these children (78%) died or underwent heart transplantation. CONCLUSIONS: HB after S1P is rare but heralds a poor outcome. Careful monitoring of these patients is recommended given their significantly increased risks of death and heart transplantation.
Authors: Matthew E Oster; Shan Chen; Nicholas Dagincourt; Yaniv Bar-Cohen; Matthew Brothers; Nicole Cain; Steven D Colan; Richard J Czosek; Jamie A Decker; David G Gamboa; Salim F Idriss; Joel A Kirsh; Martin J LaPage; Richard G Ohye; Elizabeth Radojewski; Maully Shah; Eric S Silver; Anoop K Singh; Joel D Temple; John Triedman; Jonathan R Kaltman Journal: J Thorac Cardiovasc Surg Date: 2016-11-16 Impact factor: 5.209
Authors: Andrew E Radbill; Andrew H Smith; Sara L Van Driest; Frank A Fish; David P Bichell; Bret A Mettler; Karla G Christian; Todd L Edwards; Prince J Kannankeril Journal: Cardiol Young Date: 2022-01-06 Impact factor: 1.023
Authors: Eric J Hall; Andrew H Smith; Frank A Fish; David P Bichell; Bret A Mettler; Kimberly Crum; Prince J Kannankeril; Andrew E Radbill Journal: Ann Thorac Surg Date: 2017-09-28 Impact factor: 4.330
Authors: Richard J Czosek; Jeffrey B Anderson; Shankar Baskar; Philip R Khoury; Natalie Jayaram; David S Spar Journal: Heart Rhythm Date: 2021-05-21 Impact factor: 6.343